BRA
Bender Robert & Associates Portfolio holdings
AUM
$448M
This Quarter Return
+17.29%
1 Year Return
+20.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$362M
AUM Growth
+$362M
(+12%)
Cap. Flow
-$4.87M
Cap. Flow
% of AUM
-1.34%
Top 10 Holdings %
Top 10 Hldgs %
70.9%
Holding
56
New
1
Increased
10
Reduced
33
Closed
6
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$4.44M |
| 2 |
Eli Lilly
LLY
|
$4.04M |
| 3 |
ServiceNow
NOW
|
$290K |
| 4 |
Microsoft
MSFT
|
$219K |
| 5 |
Palo Alto Networks
PANW
|
$180K |
Top Sells
| 1 |
Apple
AAPL
|
$2.61M |
| 2 |
AbbVie
ABBV
|
$2.34M |
| 3 |
VMW
VMware, Inc
VMW
|
$1.87M |
| 4 |
AstraZeneca
AZN
|
$906K |
| 5 |
Cognizant
CTSH
|
$877K |
Sector Composition
| 1 | Technology | 43.09% |
| 2 | Consumer Discretionary | 25.56% |
| 3 | Healthcare | 19.87% |
| 4 | Communication Services | 9.51% |
| 5 | Utilities | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AbbVie
ABBV
$373B
| $1.83M | 0.51% |
13,615
-17,349
| -56% | -$2.34M |
|
27
Bristol-Myers Squibb
BMY
$96.3B
| $1.81M | 0.5% |
28,297
+410
| +1% | +$26.2K |
|
|
28
Palo Alto Networks
PANW
$128B
| $1.59M | 0.44% |
6,242
+705
| +13% | +$180K |
|
29
Costco
COST
$416B
| $964K | 0.27% |
1,791
-46
| -3% | -$24.8K |
|
30
Abbott
ABT
$228B
| $888K | 0.25% |
8,141
-580
| -7% | -$63.2K |
|
31
Merck
MRK
$212B
| $867K | 0.24% |
7,516
-936
| -11% | -$108K |
|
32
Johnson & Johnson
JNJ
$428B
| $846K | 0.23% |
5,109
-422
| -8% | -$69.8K |
|
33
Paychex
PAYX
$48.8B
| $638K | 0.18% |
5,705
-1,130
| -17% | -$126K |
|
34
Boeing
BA
$180B
| $568K | 0.16% |
2,689
-251
| -9% | -$53K |
|
35
Deere & Co
DE
$128B
| $549K | 0.15% |
1,356
-205
| -13% | -$83.1K |
|
36
Nucor
NUE
$33.6B
| $535K | 0.15% |
3,260
-795
| -20% | -$130K |
|
37
Pfizer
PFE
$141B
| $520K | 0.14% |
14,185
-6,035
| -30% | -$221K |
|
38
JPMorgan Chase
JPM
$821B
| $519K | 0.14% |
3,566
-512
| -13% | -$74.5K |
|
39
BioCryst Pharmaceuticals
BCRX
$1.75B
| $483K | 0.13% |
68,600
| – | – |
|
40
UroGen Pharma
URGN
$887M
| $359K | 0.1% |
34,701
| – | – |
|
41
Caterpillar
CAT
$194B
| $350K | 0.1% |
1,422
-195
| -12% | -$48K |
|
42
Oracle
ORCL
$630B
| $285K | 0.08% |
2,389
| – | – |
|
43
Visa
V
$677B
| $266K | 0.07% |
1,120
| – | – |
|
44
Idexx Laboratories
IDXX
$51.1B
| $231K | 0.06% |
460
-5
| -1% | -$2.51K |
|
45
Target
TGT
$41.9B
| $212K | 0.06% |
1,605
-450
| -22% | -$59.4K |
|
46
Duke Energy
DUK
$94.8B
| $206K | 0.06% |
2,290
-259
| -10% | -$23.2K |
|
47
Evolus
EOLS
$488M
| $182K | 0.05% |
25,070
| – | – |
|
48
Pulse Biosciences
PLSE
$1.03B
| $74.2K | 0.02% |
+10,325
| New | +$74.2K |
|
49
Summit Therapeutics
SMMT
$17.8B
| $60.4K | 0.02% |
24,059
+10,000
| +71% | +$25.1K |
|
|
CMRX
50
DELISTED
Chimerix, Inc.
CMRX
| $12.8K | ﹤0.01% |
10,609
| – | – |
|